about
Platelet activating factor contributes to vascular leak in acute dengue infection.The mucosal immune response to laryngopharyngeal reflux.Psoriatic T cells recognize neolipid antigens generated by mast cell phospholipase delivered by exosomes and presented by CD1aA role for IL-25 and IL-33-driven type-2 innate lymphoid cells in atopic dermatitis.Cytokine regulation of the epidermal barrier.Histamine enhances keratinocyte-mediated resolution of inflammation by promoting wound healing and response to infection.IL-17 downregulates filaggrin and affects keratinocyte expression of genes associated with cellular adhesion.Immunologic response of the laryngeal mucosa to extraesophageal reflux.Expanded population of CD1d-restricted Vα24+ cells in a patient with active rheumatoid arthritis.Therapeutic vaccines for allergic disease.Orchestrated control of filaggrin-actin scaffolds underpins cornification.Proliferatory defect of invariant population and accumulation of non-invariant CD1d-restricted natural killer T cells in the joints of RA patientsThe histamine-synthesizing enzyme histidine decarboxylase is upregulated by keratinocytes in atopic skinFilaggrin-insufficiency in keratinocytes influences responsiveness of allergen-specific T cells to cognate antigen and compounds barrier function deficiencyHistamine exerts multiple effects on expression of genes associated with epidermal barrier function2-Dimensional gel electrophoresis and MALDI-MS of cystic cervical metastasis from head and neck squamous cell carcinomaInterleukin-22 downregulates filaggrin expression and affects expression of profilaggrin processing enzymesProof-of-concept clinical trial of etokimab shows a key role for IL-33 in atopic dermatitis pathogenesisRe-evaluation of human BDCA-2+ DC during acute sterile skin inflammation
P50
Q35043739-C2E96E5D-DD89-4537-89BA-B90E8484F9D3Q37098434-9C954509-A008-4B3F-85D2-37BC58157990Q37346670-DD293618-C424-423B-AED5-03045A2BB842Q37397800-CA72568D-54B6-4ED7-99F6-CFB24C111A1BQ38109697-FD447677-2E05-4AEB-B717-B9429088DBD0Q38480663-AD988B76-CE37-4A6D-8341-CF1B3B9D60FBQ38498941-E449F4D6-F202-4BA6-A2FB-75AF11457FA0Q45280706-ECE4B7DB-E834-463C-AA89-FD7C6E930062Q46083674-B02E25DD-119B-46D8-8564-C8C7E6D17D33Q47100584-D9B3F32F-E196-4F63-AFE9-E88D4C710159Q52353740-DE6DC424-81D4-4910-B457-1829627CF722Q57474021-B8FC2EDB-6A8C-422C-A2D7-A3BC02C23BA1Q60474915-2A7AF18C-3363-4630-A247-32A251DC5C14Q60474919-033408A2-80A8-4AB9-8A93-376BBD484F4BQ60474976-738DF7C4-238E-4F31-AC08-58CEAA63A262Q60474980-2FC51177-E92D-476D-97C1-9AE216AF3E65Q60474988-F52F1D79-5D6F-4A3C-B885-B7DCF4DFDAA5Q90910388-EDB95F4C-3822-41D7-8E47-C8F7293FB777Q92039944-5ECD421F-73E2-45B7-8036-8EDE3648F618
P50
description
hulumtuese
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Danuta Gutowska-Owsiak
@ast
Danuta Gutowska-Owsiak
@en
Danuta Gutowska-Owsiak
@es
Danuta Gutowska-Owsiak
@nl
Danuta Gutowska-Owsiak
@sl
type
label
Danuta Gutowska-Owsiak
@ast
Danuta Gutowska-Owsiak
@en
Danuta Gutowska-Owsiak
@es
Danuta Gutowska-Owsiak
@nl
Danuta Gutowska-Owsiak
@sl
prefLabel
Danuta Gutowska-Owsiak
@ast
Danuta Gutowska-Owsiak
@en
Danuta Gutowska-Owsiak
@es
Danuta Gutowska-Owsiak
@nl
Danuta Gutowska-Owsiak
@sl
P106
P21
P31
P496
0000-0003-4503-2279